European regulators have approved the first malaria vaccine that has the potential to save thousands of infants from contracting the killer disease, Anthem formally agreed to buy Cigna for $48.4 billion now there's just the potential antitrust issues to sweat through.
Bay Area startup SutroVax just raised $22 million for work in developing conjugate vaccines - and likely improving upon existing inoculations for pneumococcal conditions.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Despite being neglected for several years, a surprisingly effective cholera vaccine is emerging as an inexpensive solution to an epidemic-level problem, a new Lancet study finds.
Vasculotide helps prevent against influenza by targeting fluid leakage in lungs instead of attacking the sometimes deadly virus directly.
A Cambridge startup called Vaxxas that’s developing vaccines worn on the skin as patches just raised a $20 million Series B. The funding will be used to bring its Nanopatch platform to clinical trial, and to flesh out its pipeline of needle-free vaccines. The Nanopatch works by riling up the immune cells just below the skin’s surface, inducing […]
New Jersey’s VaxInnate is developing inoculations to ward off seasonal and pandemic flu, dengue fever and Clostridium difficile. The well-capitalized company has raised a recent round of $6 million, according to a regulatory filing. The company genetically fuses vaccine antigens to flagellin, a protein that forms the flagella of a bacterium that’s known for being highly […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The World Health Organization just finished up a two-day meeting to debate whether they should allow an Ebola vaccine to be administered in the field without having tested efficacy, NPR reports. The disease’s spread is alarming, and traditional containment methods like isolation just aren’t working well enough. But while an untested Ebola vaccine given to […]
A group of — get this — high school students from Carlsbad, California have produced a documentary on the contentious debate over whether childhood vaccinations cause autism. They’re doing this despite anti-vaccer protests, and even a teacher who suggested the issue is just too much of a hot button. The group worked on “Invisible Threat” for a […]
The two Ebola-infected Americans recently evacuated from Liberia were given an experimental drug that probably saved their lives, but Popular Science raises an interesting point – no Africans are likely to get the same treatment. Not anytime soon, that is. Kent Brantly and Nancy Writebol, the two volunteers in an Ebola clinic that contracted the deadly virus, […]
The Amish countryside in central Ohio looks like it has for a hundred years. There are picturesque pastures with cows and sheep, and big red barns dot the landscape. But something changed here when, on an April afternoon, an Amish woman walked to a communal call box. She called the Knox County Health Department and […]
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Cleveland biotech company Western Oncolytics is developing an immune-oncolytic therapy licensed by the University of Pittsburgh which combines oncolytic virus and gene therapy technologies to rid cancer cells of the ability to survive in the body. According to their website, the company expects their technology to extend the lives of, or even cure, patients with an array of […]
With a little genetic engineering, the vaccine that was key in helping eradicate smallpox more than 30 years ago could also be key in curing cancer, if a young Cleveland biotech has anything to say about it. Western Oncolytics is developing a dual-mechanism therapy that combines oncolytic virus and gene therapy technologies with the hope […]
An academia-industry partnership between Ohio State University and biopharmaceutical company MedVax Technologies will take a new vaccine aimed at preventing and treating certain kinds of cancers through clinical development. The vaccine, developed by Ohio State researchers, targets cancers associated with the HER2 protein, which is thought to play a role not only in breast cancer […]
Analysts say there’s a multibillion-dollar market up for the taking for companies who figure out how to turn on the immune system to fight tumor cells and delay the progression of cancer. Canadian company Immunovaccine wants a piece of that market and today said it’s reached an important milestone in getting there. Immunovaccine just raised […]
Inovio Pharmaceuticals (NYSE AMEX: INO) has teamed up with affiliate VGX International to finance clinical development of the Blue Bell, Pennsylvania-based drug developer’s therapeutic vaccines for hepatitis B and C infections. Under the terms of the deal, VGX will receive marketing rights for the vaccines in Asia, but Inovio will hold onto the lucrative Japanese […]